vipidia 25mg tablets
takeda uk ltd - alogliptin benzoate - tablet - 25mg
nesina tablet
takeda canada inc - alogliptin (alogliptin benzoate) - tablet - 6.25mg - alogliptin (alogliptin benzoate) 6.25mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
nesina tablet
takeda canada inc - alogliptin (alogliptin benzoate) - tablet - 12.5mg - alogliptin (alogliptin benzoate) 12.5mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
nesina tablet
takeda canada inc - alogliptin (alogliptin benzoate) - tablet - 25mg - alogliptin (alogliptin benzoate) 25mg - dipeptidyl peptidase-4 (dpp-4) inhibitors
nesina met film coated tablet 12.5mg1000mg
takeda pharmaceuticals (asia pacific) pte. ltd. - alogliptin benzoate eqv. alogliptin; metformin hydrochloride - tablet, film coated - alogliptin benzoate eqv. alogliptin 12.5mg; metformin hydrochloride 1000 mg
vipidia
takeda pharma a/s - alogliptin - diabetes mellitus, type 2 - drugs used in diabetes, dipeptidyl peptidase 4 (dpp-4) inhibitors - vipidia is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control in combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).
alogliptin 12.5mg / metformin 1g tablets
ennogen healthcare ltd - metformin hydrochloride; alogliptin benzoate - oral tablet - 1gram ; 12.5mg
alogliptin 12.5mg / metformin 1g tablets
j m mcgill ltd - metformin hydrochloride; alogliptin benzoate - oral tablet - 1gram ; 12.5mg
alogliptin 12.5mg / metformin 1g tablets
niche pharma ltd - metformin hydrochloride; alogliptin benzoate - oral tablet - 1gram ; 12.5mg
alogliptin 12.5mg / metformin 1g tablets
colorama pharmaceuticals ltd - metformin hydrochloride; alogliptin benzoate - oral tablet - 1gram ; 12.5mg